- TheStreet.com•15 days ago
Ionis Pharmaceuticals (IONS) stock was falling on Thursday after drugmaker Alnylam Pharmaceuticals (ALNY) discontinued the development of a gene-silencing drug.
- Motley Fool•16 days ago
Both companies have agreements with a biotechnology giant, but which one is better positioned for years of growth?
Ionis Pharmaceuticals, Inc (ISIS)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
At close: 4:00 PM EST
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|